Meridian Bioscience

Meridian Bioscience Dividend per Share

The Dividend per Share of Meridian Bioscience (VIVO) as of Oct 5, 2026 is 0.13 USD. In the previous year, Dividend per Share was 0.50 USD — a change of -75.00% (lower).

Dividend per Share

0.13USD

YoY

-75.00%

Last updated:

Dividend per Share of Meridian Bioscience is 2026 0.13 USD. Dividend per Share of Meridian Bioscience was 2025 0.50 USD. It decreases by -75.00% lower compared to the previous year.

At today's price the dividend yield works out to roughly 3.70%. The payout ratio is around 22% of earnings.

The Meridian Bioscience Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2018
0.50 USD
Jan 1, 2019
0.13 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023 (e)
0.00 USD
Jan 1, 2024 (e)
0.00 USD
Jan 1, 2025 (e)
0.00 USD
The Meridian Bioscience Dividend per Share history
YEARDividend per ShareYoY
est0.00USD—
est0.00USD—
est0.00USD—
0.00USD—
0.00USD—
0.00USD-100.00%
0.13USD-75.00%
0.50USD0.00%
0.50USD-37.50%
0.80USD0.00%
0.80USD0.00%
0.80USD+5.26%
0.76USD-20.00%
0.95USD+25.00%
0.76USD0.00%
0.76USD+11.76%
0.68USD+21.43%
0.56USD+29.23%
0.43USD+41.30%
0.31USD+43.75%
0.21USD+20.00%
0.18USD+11.11%
0.16USD—
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Dividend per Share of Meridian Bioscience is 0.13 USD in 2026.

Dividend per Share of Meridian Bioscience changed from 0.50 USD to 0.13 USD, representing a -75.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend per Share Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Dividend — Meridian Bioscience

All Key Metrics — Meridian Bioscience